Isao Ohashi

A landmark in drug discovery based on complex natural product synthesis

T. Owa, T. Akagi, A. Yokoi, 2019, Scientific Reports.

A landmark in drug discovery based on complex natural product synthesis

T. Owa, T. Akagi, A. Yokoi, 2019, Scientific Reports.

E7090, a Novel Selective Inhibitor of Fibroblast Growth Factor Receptors, Displays Potent Antitumor Activity and Prolongs Survival in Preclinical Models

T. Nakagawa, Yuji Yamamoto, K. Okamoto, 2016, Molecular Cancer Therapeutics.

What Does It Take to Develop Structurally Complex Molecules by Total Synthesis? Rapid Process Development and GMP Manufacturing of E7130 Drug Substance for First-in-Human Clinical Study

S. Nagao, Kenzo Yahata, Yosuke Kaburagi, 2024, Organic Process Research & Development.

Ten-Gram-Scale Total Synthesis of the Anticancer Drug Candidate E7130 to Supply Clinical Trials.

S. Nagao, Kenzo Yahata, K. Iso, 2024, Organic letters.